tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CAPR Stock Latest News

Capricor Therapeutics price target raised to $15 from $14 at Oppenheimer
The FlyCapricor Therapeutics price target raised to $15 from $14 at Oppenheimer
11h ago
CAPR
Capricor expands partnership with Nippon in Europe, says Maxim
PremiumThe Fly
Capricor expands partnership with Nippon in Europe, says Maxim
15h ago
CAPR
Capricor Therapeutics Secures Lucrative European Partnership
PremiumCompany Announcements
Capricor Therapeutics Secures Lucrative European Partnership
17h ago
8K
CAPR
Capricor Therapeutics enters deramiocel term sheet with Nippon Shinyaku
PremiumThe Fly
Capricor Therapeutics enters deramiocel term sheet with Nippon Shinyaku
17h ago
CAPR
Capricor signs term sheet with Nippon Shinyaku for deramiocel commercialization
PremiumThe Fly
Capricor signs term sheet with Nippon Shinyaku for deramiocel commercialization
17h ago
CAPR
Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
PremiumPress ReleasesCapricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
17h ago
CAPR
Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
Premium
Press Releases
Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
12d ago
CAPR
Capricor Therapeutics reports Q2 EPS (35c), consensus (36c)
Premium
The Fly
Capricor Therapeutics reports Q2 EPS (35c), consensus (36c)
1M ago
CAPR
CAPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CAPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CAPR
Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7
PremiumPress Releases
Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7
2M ago
CAPR
Capricor Therapeutics to join Russell 2000, Russell 3000 indexes
PremiumThe Fly
Capricor Therapeutics to join Russell 2000, Russell 3000 indexes
3M ago
CAPR
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
PremiumPress Releases
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
3M ago
CAPR
Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
PremiumPress ReleasesCapricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
3M ago
CAPR
Capricor announces three-year safety, efficacy results from HOPE-2 OLE study
Premium
The Fly
Capricor announces three-year safety, efficacy results from HOPE-2 OLE study
3M ago
CAPR
CORRECTION: Capricor Therapeutics
Premium
Press Releases
CORRECTION: Capricor Therapeutics
3M ago
CAPR
Capricor Therapeutics announces Pre-BLA meeting for CAP-1002
PremiumThe Fly
Capricor Therapeutics announces Pre-BLA meeting for CAP-1002
3M ago
CAPR
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
PremiumPress Releases
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
3M ago
CAPR
Capricor Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Capricor Therapeutics files $150M mixed securities shelf
3M ago
CAPR
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
PremiumPress Releases
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
3M ago
CAPR
Capricor Therapeutics completes Type B meeting with FDA for CAP-1002 program
PremiumThe FlyCapricor Therapeutics completes Type B meeting with FDA for CAP-1002 program
3M ago
CAPR
Capricor Therapeutics announces 3-year efficacy results from HOPE-2 OLE study
Premium
The Fly
Capricor Therapeutics announces 3-year efficacy results from HOPE-2 OLE study
4M ago
CAPR
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
Premium
Press Releases
Capricor Therapeutics Announces Positive 3-Year Efficacy Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
4M ago
CAPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >